![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, June 15, 2024 2:55:51 PM
My post is purely based on the asset disclosure that was filed, which of course does not include Lenzilumab as it has been sold to Taran. If management truly is doing something clever to help out shareholders that would be incredible, and I hope it is the case. My current viewpoint, despite being unfortunate, is only based on what I can read in the mass amount of filings I've reviewed.
I've still got my fingers crossed. I'm fairly certain we'll find out rather soon.
In any event, here is the link I promised to share where all dockets can be pulled: https://dm.epiq11.com/case/humanigen/info
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM